Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Psychotic Disorders market in Bahrain is experiencing steady growth due to several key factors.
Customer preferences: In Bahrain, there is a growing awareness and acceptance of mental health issues, including psychotic disorders. This has led to an increased demand for effective treatments and therapies. Customers are seeking out options that can help manage their symptoms and improve their quality of life. They are also looking for treatments that are convenient and accessible, with a preference for outpatient care rather than inpatient hospitalization.
Trends in the market: One of the main trends in the Psychotic Disorders market in Bahrain is the shift towards a more holistic approach to treatment. Customers are increasingly interested in complementary and alternative therapies, such as mindfulness meditation and yoga, as adjuncts to traditional medication. This trend is driven by a desire for a more personalized and integrated approach to mental health care. Another trend in the market is the growing use of telemedicine and digital health solutions. This allows patients to access care remotely, which is particularly beneficial for those who live in remote areas or have limited mobility. Telemedicine also offers a convenient option for follow-up appointments and medication management.
Local special circumstances: Bahrain has a relatively small population compared to other countries in the region. This means that the market size for Psychotic Disorders treatments is smaller, but it also allows for more targeted and specialized care. Healthcare providers in Bahrain have the opportunity to focus on individualized treatment plans and provide a high level of personalized care to their patients.
Underlying macroeconomic factors: Bahrain has a strong healthcare system and invests heavily in healthcare infrastructure. This provides a solid foundation for the development and growth of the Psychotic Disorders market. The government has also implemented policies to improve mental health services and increase access to care. These initiatives have contributed to the overall growth of the market. In conclusion, the Psychotic Disorders market in Bahrain is growing steadily due to increasing customer awareness and acceptance of mental health issues, as well as a shift towards holistic and personalized treatment approaches. The use of telemedicine and digital health solutions is also on the rise, providing convenient and accessible care options. Bahrain's small population size allows for targeted and specialized care, while the strong healthcare system and government initiatives support the growth of the market.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights